Difference between revisions of "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265) (Q8388)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: has part (P22): Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) (Q8406), #quickstatements; #temporary_batch_1589491516652)
(‎Changed [en] description: Research article published in Emerg Microbes Infect; 2020; 9(1) 582-585.)
 
(13 intermediate revisions by the same user not shown)
description / endescription / en
-
Research article published in the journal Emerg Microbes Infect (2020)
+
Research article published in Emerg Microbes Infect; 2020; 9(1) 582-585.
Property / has part
 +
Property / has part: Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Disclosure statement (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank

Latest revision as of 11:56, 17 May 2020

Research article published in Emerg Microbes Infect; 2020; 9(1) 582-585.
Language Label Description Also known as
English
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265)
Research article published in Emerg Microbes Infect; 2020; 9(1) 582-585.

    Statements

    Coronavirus disease 2019
    0 references
    SARS-CoV-2
    0 references
    pneumonia
    0 references
    diagnosis
    0 references
    treatment
    0 references
    Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (English)
    51b99ff77b798aa00a8a10ecb4f62312a3f562d2